Bio Path Holdings IncBio Path Holdings Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Complete Sustainability analysis of Bio Path Holdings Inc can be accessed by registering for free. The assessment of Bio Path Holdings Inc leverages data points from across the internet and also from available documents by Bio Path Holdings Inc. The ESG rating includes 17 UN SDGs including: 'Good Health & Wellbeing', 'Industry, Innovation & Infrastructure' and 'Partnerships for the Goals'.

Bio Path Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.4; made up of an environmental score of 5.3, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Bio Path Holdings Inc 
Low
0 - 3
Medium
4 - 6

7.4

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Bio Path Holdings Inc 
5.3

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
256Sun Pharma Advanced Research Co Ltd
7.5
High
256Prostatype Genomics AB
7.5
High
288Bio Path Holdings Inc
7.4
High
288Bionano Genomics Inc
7.4
High
288Chugai Pharmaceutical Co Ltd
7.4
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Bio Path Holdings Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Bio Path Holdings Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Bio Path Holdings Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Bio Path Holdings Inc offer flexible work?

LockedSign up for free to unlock

Does Bio Path Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Bio Path Holdings Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Bio Path Holdings Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose water use targets?

LockedSign up for free to unlock

Does Bio Path Holdings Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Bio Path Holdings Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Bio Path Holdings Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Bio Path Holdings Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Bio Path Holdings Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Bio Path Holdings Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Bio Path Holdings Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose its waste policy?

LockedSign up for free to unlock

Does Bio Path Holdings Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose energy use targets?

LockedSign up for free to unlock

Does Bio Path Holdings Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Bio Path Holdings Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Bio Path Holdings Inc
These potential risks are based on the size, segment and geographies of the company.

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

Sorry!

Failed to process!